🧪
hypothesis

Membrane Lipid Composition-Dependent Specificity Switch Enabling Cross-Seeding Recognition

Hypothesis

Membrane Lipid Composition-Dependent Specificity Switch Enabling Cross-Seeding Recognition

Specific lipid perturbations (bis(monoacylglycero)phosphate enrichment, cardiolipin externalization) create membrane microenvironments that expose distinct amyloid-competent conformers, allowing one misfolded protein to template another'.
🧬 PLD3🩺 neurodegeneration🎯 Composite 46%💱 $0.52▲5.2%active
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite46%

🧪 Overview

Specific lipid perturbations (bis(monoacylglycero)phosphate enrichment, cardiolipin externalization) create membrane microenvironments that expose distinct amyloid-competent conformers, allowing one misfolded protein to template another's beta-sheet formation with lipid-mediated specificity.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Lysosomal Membrane Stress<br/>PLD3 Dysfunction or Mutation"]
    B["BMP Bis-Monoacylglycerophosphate Enrichment<br/>Late Endosome Lipid Signature"]
    C["Cardiolipin Externalization<br/>Mitochondrial Lipid Exposed"]
    D["Membrane Microenvironment Switch<br/>Unique Lipid Topology Created"]
    E["Amyloid-Competent Conformer Exposure<br/>Protein Misfolding Nucleation Sites"]
    F["Cross-Seeding Recognition Events<br/>Specificity Switched by Lipid Context"]
    G["Multi-Protein Aggregate Propagation<br/>Tau-SNCA-TDP43 Co-Seeding"]
    A --> B
    A --> C
    B --> D
    C --> D
    D --> E
    E --> F
    F --> G
    style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports3 contradicts
Supports
Alzheimer's disease risk genes and mechanisms of disease pathogenesis.
Biol Psychiatry2015PMID:24951455medium
Supports
Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism.
Nat Commun2023PMID:37225734medium
Supports
PLD3 affects axonal spheroids and network defects in Alzheimer's disease.
Nature2022PMID:36450991medium
Supports
PLD3 in Alzheimer's disease.
Mol Neurobiol2015PMID:24935720medium
Supports
PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.
PLoS Genet2021PMID:33830999medium
Contradicts
Alzheimer's disease risk genes and mechanisms of disease pathogenesis.
Biol Psychiatry2015PMID:24951455medium
Contradicts
PLD3 in Alzheimer's disease.
Mol Neurobiol2015PMID:24935720medium
Contradicts
Genetics of Alzheimer's disease.
Adv Genet2014PMID:25311924medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — PLD3

No curated PDB or AlphaFold mapping for PLD3 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for PLD3 →

No DepMap CRISPR Chronos data found for PLD3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0509
Events (7d)
0
Price History
▲5.2%

💾 Resource Usage

LLM Tokens
10,754
$0.0444
Total Cost
$0.0444
View on SciDEX ↗